Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
qianqing zhang
(9 results)?
Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2143154. doi: 10.1080/21645515.2022.2143154. Epub 2022 Nov 22.
Hum Vaccin Immunother. 2022.
PMID: 36412232
Free PMC article.
The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis.
Zhang Q, Gong X, Sun L, Miao L, Zhou Y.
Zhang Q, et al.
Front Oncol. 2022 Jul 18;12:791496. doi: 10.3389/fonc.2022.791496. eCollection 2022.
Front Oncol. 2022.
PMID: 35924149
Free PMC article.
Item in Clipboard
Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer.
Wang Y, Gong X, Hu Y, Yi Q, Zhang Q, Miao L, Zhou Y.
Wang Y, et al. Among authors: zhang q.
Front Oncol. 2022 Jun 20;12:873709. doi: 10.3389/fonc.2022.873709. eCollection 2022.
Front Oncol. 2022.
PMID: 35795057
Free PMC article.
Item in Clipboard
Association of Brain Metastases With Immune Checkpoint Inhibitors Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.
Wang Y, Zhang Q, Chen C, Hu Y, Miao L, Zhou Y.
Wang Y, et al. Among authors: zhang q.
Front Oncol. 2021 Dec 8;11:721760. doi: 10.3389/fonc.2021.721760. eCollection 2021.
Front Oncol. 2021.
PMID: 34956860
Free PMC article.
Item in Clipboard
Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor in a patient with recurrent non-small cell lung cancer: A case report.
Zhang QN, Li Y, Zhao Q, Tian M, Chen LL, Miao LY, Zhou YJ.
Zhang QN, et al.
Thorac Cancer. 2021 May;12(10):1617-1619. doi: 10.1111/1759-7714.13947. Epub 2021 Mar 24.
Thorac Cancer. 2021.
PMID: 33760389
Free PMC article.
Item in Clipboard
Nivolumab in combination with anlotinib achieved remarkable efficacy in a patient with driver-negative lung squamous cell carcinoma and PS of 4.
Wang Y, Zhang Q, Miao L, Zhou Y.
Wang Y, et al. Among authors: zhang q.
Ann Palliat Med. 2020 Nov;9(6):4384-4388. doi: 10.21037/apm-20-2096.
Ann Palliat Med. 2020.
PMID: 33302689
Free article.
Item in Clipboard
Cite
Cite